Cargando…
GCT-29. DOES TUMOUR MARKER DECLINE PREDICT OUTCOME IN INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCTs)?
INTRODUCTION: The prognostic impact of tumour marker (TM) decline rate has been demonstrated for extracranial poor prognostic non-seminomatous/germinomatous germ cell tumours (NGGCT). The current series aimed to assess if this finding can be applied to intracranial primaries. METHODS: Patients were...
Autores principales: | Conter, Cecile Faure, Lardy-Cleaud, Audrey, Murray, Matthew, Nicholson, James, Guerrini-Rousseau, Lea, Palenzuela, Gilles, Alapetite, Claire, Garre, Maria Louise, Kortmann, Rolf, Saran, Frank, Ajithkumar, Thankamma, Pietsch, Torsten, Vasiljevic, Alexandre, Ricardi, Umberto, Timmermann, Beate, Muller, Jans Enno, Calaminus, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715924/ http://dx.doi.org/10.1093/neuonc/noaa222.249 |
Ejemplares similares
-
GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020) -
GCT-12. SIOP CNS GCT II: High Risk (HR) CNS Non-germinomatous Germ Cell Tumours (NGGCT) treated with Dose intensified PEI – final results
por: Calaminus, Gabriele, et al.
Publicado: (2022) -
GCT-20. EVALUATION OF NEURORADIOLOGICAL RESPONSE TO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH LOCALISED GERMINOMA IN THE SIOP CNS GCT II TRIAL
por: Bison, Brigitte, et al.
Publicado: (2020) -
GCT-40. PROGNOSTIC FACTORS FOR PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)
por: Abu-Arja, Mohammad H, et al.
Publicado: (2020) -
GCT-11. 24 Gy whole ventricular radiotherapy alone is sufficient for disease control in localised germinoma in CR after initial chemotherapy – final of the SIOP CNS GCT II study
por: Calaminus, Gabriele, et al.
Publicado: (2022)